From Surf Wiki (app.surf) — the open knowledge base
3,4-Methylenedioxyphentermine
Chemical compound
Chemical compound
| Field | Value | |||
|---|---|---|---|---|
| Verifiedfields | changed | |||
| Watchedfields | changed | |||
| verifiedrevid | 424870031 | |||
| drug_name | MDPH | |||
| image | Methylenedioxyphentermine.svg | |||
| image_class | skin-invert-image | |||
| width | 225px | |||
| routes_of_administration | Oral | |||
| class | Psychoactive drug | |||
| ATC_prefix | None | |||
| duration_of_action | 3–5 hours | |||
| CAS_number_Ref | ||||
| CAS_number | 39235-63-7 | |||
| PubChem | 13020598 | |||
| ChemSpiderID_Ref | ||||
| ChemSpiderID | 15204207 | |||
| UNII | WF9K2PM8J8 | |||
| ChEMBL | 126226 | |||
| synonyms | MDP; MDPH; 3,4-Methylenedioxyphentermine; 3,4-Methylenedioxy-α,α-dimethylphenethylamine | |||
| IUPAC_name | 1-(2H-1,3-benzodioxol-5-yl)-2-methylpropan-2-amine | |||
| C | 11 | H=15 | N=1 | O=2 |
| SMILES | NC(C)(C)CC1=CC(OCO2)=C2C=C1 | |||
| StdInChI_Ref | ||||
| StdInChI | 1S/C11H15NO2/c1-11(2,12)6-8-3-4-9-10(5-8)14-7-13-9/h3-5H,6-7,12H2,1-2H3 | |||
| StdInChIKey_Ref | ||||
| StdInChIKey | OIZBHKBNZXRXSM-UHFFFAOYSA-N |
| Drugs.com =
| elimination_half-life =
3,4-Methylenedioxyphentermine (MDPH) is a psychoactive drug of the amphetamine family. MDPH was first synthesized by Alexander Shulgin. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.
Use and effects
In his book PiHKAL (Phenethylamines i Have Known And Loved), the dose range is listed as 160–240 mg, and the duration as 3 to 5hours. MDPH's effects are very similar to those of MDA: they both are smooth and "stoning," and do not cause any visuals. They also alter dreams and dream patterns. But it is said to have none of the magic of MDMA. Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to 2C-D.
Chemistry
Synthesis
The chemical synthesis of MDPH has been described.
Analogues
The N-methyl derivative, 3,4-methylenedioxy-N-methylphentermine (MDMPH), has been described by Shulgin as lacking MDMA-like effects. Accordingly, MDMPH, as well as MDPH, were found to be inactive as serotonin releasing agents in vitro.
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
References
References
- {{CitePiHKAL [http://www.erowid.org/library/books_online/pihkal/pihkal116.shtml MDPH entry in ''PiHKAL'']
- (1990). "Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA". Springer US.
- (May 1982). "Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes". Journal of Medicinal Chemistry.
- "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about 3,4-Methylenedioxyphentermine — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report